Authors' reply to “Statin treatment and cerebral microbleeds: A risk assessment”

We appreciate Dr. Kawada for his interest in our systematic review and meta-analysis investigating the association between statin treatment and cerebral microbleeds (CMBs) [1]. In this systematic review and meta-analysis we analyzed cross-sectional evidence from available cohorts nested within randomized-controlled clinical trials or observational studies [2]. In the overall analysis statin treatment was not found to be associated with CMBs presence, but when the analysis was restricted to lobar CMBs the association between statin use and the probability for lobar CMBs presence was positive [2].
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Response to letter to the Editor Source Type: research

Related Links:

Front Cardiovasc Med. 2021 Nov 15;8:674248. doi: 10.3389/fcvm.2021.674248. eCollection 2021.ABSTRACTBackground: Acute disturbances of the lipid profile are commonplace during acute sepsis episode. However, their long-term persistence has not to be investigated despite pivotal role of dyslipidemia in several comorbidities excessively noted in sepsis survivors (stroke, cardiomyopathy). Methods: A total of 9,861 individuals hospitalized for a singular episode of sepsis between 2009 and 2019 were identified from electronic medical records. Lab measurements of total cholesterol (Tchol), high-density lipoprotein (HDL-c), low-den...
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research
Ther Adv Endocrinol Metab. 2021 Nov 24;12:20420188211058323. doi: 10.1177/20420188211058323. eCollection 2021.ABSTRACTLandmark studies have convincingly demonstrated that atherosclerosis begins in youth. While generally asymptomatic, an increasing number of youth with disorders of lipid and lipoprotein metabolism, such as familial hypercholesterolemia, are being identified through selective and universal screening. While a heart healthy lifestyle is the foundation of treatment for all youth with dyslipidemia, lipid-lowering therapy may be required by some to prevent morbidity and premature mortality, especially when initia...
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research
In this study, we explore the cardioprotective and anti-atherosclerosis effect of sinomenine against Vitamin D3 and High fat induced atherosclerosis in rats. Sprague Dawley (SD) rats were used in this study. The rats were received the vitamin D (60000) and High fat diet to induce the atherosclerosis and divided into groups and received the oral administration of sinomenine (2.5, 5 and 10 mg/kg) and simvastatin (5 mg/kg). Body weight, organ weight and biochemical parameters were estimated. The mRNA expression of MyD88, TLR4, NF-κB and IκB were estimated. Sinomenine treated rats significantly (p
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research
A new study reveals benefit to high-intensive statin therapy among very-high-risk patients, even if their baseline LDL-C levels are low.Journal of the American College of Cardiology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Dermatology
Source: Dermatology - Category: Dermatology Source Type: research
AbstractPurpose of ReviewWe evaluated the role of CAC in guiding primary prevention with lipid-lowering medications and aspirin.Recent FindingsZero CAC is associated with low risk of future CVD events. Statin use does not weaken the prognostic utility of CAC. CAC scoring has clinical utility in patients with severe primary hypercholesteremia, hypertension, diabetes/metabolic syndrome, and in the young and older adults. The timing for repeat CAC measurement depends on baseline ASCVD risk and generally varies from 3 to 7  years.SummaryCAC is a cost-effective risk stratification approach useful in guiding shared clinical...
Source: Current Cardiovascular Imaging Reports - Category: Radiology Source Type: research
STATINS are a commonly prescribed medication for people at risk of heart attacks or who have had heart attacks previously. Serious side effects are exceedingly rare.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
STATINS are one of the most commonly prescribed drugs in the UK by around 8 million adults. They became available in the late 1980s, and there have been several reported side effects.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
In this study, they found these drugs can kill senescent cells from cultures of human fat tissue. The tissue was donated by individuals with obesity who were known to have metabolic troubles. Without treatment, the human fat tissues induced metabolic problems in immune-deficient mice. After treatment with dasatinib and quercetin, the harmful effects of the fat tissue were almost eliminated. Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity Insulin resistance is a pathological state often associated with obesity, representing a major risk factor for type 2...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
STATINS are a type of medicine used to help lower the risk of heart problems caused by high cholesterol. As with all medications, side effects can occur when taking statins - but what are the most commonly reported symptoms you should know?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Brain | Cholesterol | Clinical Trials | Neurology | Statin Therapy | Study